BR0306789A - Uso de tibolona e método de tratamento de queixas relacionadas com a deficiência do estrogênio em pacientes do sexo feminino - Google Patents
Uso de tibolona e método de tratamento de queixas relacionadas com a deficiência do estrogênio em pacientes do sexo femininoInfo
- Publication number
- BR0306789A BR0306789A BR0306789-0A BR0306789A BR0306789A BR 0306789 A BR0306789 A BR 0306789A BR 0306789 A BR0306789 A BR 0306789A BR 0306789 A BR0306789 A BR 0306789A
- Authority
- BR
- Brazil
- Prior art keywords
- complaints
- estrogen
- tibolone
- treatment
- estrogen deficiency
- Prior art date
Links
- 206010030247 Oestrogen deficiency Diseases 0.000 title abstract 3
- WZDGZWOAQTVYBX-XOINTXKNSA-N tibolone Chemical compound C([C@@H]12)C[C@]3(C)[C@@](C#C)(O)CC[C@H]3[C@@H]1[C@H](C)CC1=C2CCC(=O)C1 WZDGZWOAQTVYBX-XOINTXKNSA-N 0.000 title abstract 3
- 229960001023 tibolone Drugs 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 229940011871 estrogen Drugs 0.000 abstract 3
- 239000000262 estrogen Substances 0.000 abstract 3
- 210000000481 breast Anatomy 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 206010065687 Bone loss Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 229940041181 antineoplastic drug Drugs 0.000 abstract 1
- 239000003886 aromatase inhibitor Substances 0.000 abstract 1
- 229940046844 aromatase inhibitors Drugs 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 102000015694 estrogen receptors Human genes 0.000 abstract 1
- 108010038795 estrogen receptors Proteins 0.000 abstract 1
- 230000001076 estrogenic effect Effects 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02075235 | 2002-01-22 | ||
| PCT/EP2003/000373 WO2003061665A1 (en) | 2002-01-22 | 2003-01-16 | Tibolone in the treatment of complaints associated with the administration of drugs which prevent the synthesis of endogenous estrogen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0306789A true BR0306789A (pt) | 2004-12-28 |
Family
ID=27589110
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0306789-0A BR0306789A (pt) | 2002-01-22 | 2003-01-16 | Uso de tibolona e método de tratamento de queixas relacionadas com a deficiência do estrogênio em pacientes do sexo feminino |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20050124592A1 (https=) |
| EP (1) | EP1469861A1 (https=) |
| JP (1) | JP2005518412A (https=) |
| KR (1) | KR20040073572A (https=) |
| CN (1) | CN1620298A (https=) |
| BR (1) | BR0306789A (https=) |
| CA (1) | CA2472240A1 (https=) |
| EC (1) | ECSP045179A (https=) |
| HR (1) | HRP20040635A2 (https=) |
| IL (1) | IL162769A0 (https=) |
| IS (1) | IS7338A (https=) |
| MX (1) | MXPA04007071A (https=) |
| PL (1) | PL371181A1 (https=) |
| RU (1) | RU2004125594A (https=) |
| WO (1) | WO2003061665A1 (https=) |
| ZA (1) | ZA200405262B (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0302572D0 (en) | 2003-02-05 | 2003-03-12 | Astrazeneca Ab | Method of treatment |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE63051B1 (en) * | 1989-03-18 | 1995-03-22 | Akzo Nv | Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one |
| ES2134313T3 (es) * | 1993-03-05 | 1999-10-01 | Akzo Nobel Nv | Utilizacion de derivados de pregnano para el tratamiento de tumores. |
| EP1102755B1 (en) * | 1998-08-07 | 2006-01-04 | Chiron Corporation | Substituted isoxazole derivatives as estrogen receptor modulators |
-
2003
- 2003-01-16 JP JP2003561609A patent/JP2005518412A/ja active Pending
- 2003-01-16 CN CNA038025108A patent/CN1620298A/zh active Pending
- 2003-01-16 US US10/502,444 patent/US20050124592A1/en not_active Abandoned
- 2003-01-16 BR BR0306789-0A patent/BR0306789A/pt not_active IP Right Cessation
- 2003-01-16 PL PL03371181A patent/PL371181A1/xx not_active Application Discontinuation
- 2003-01-16 KR KR10-2004-7011160A patent/KR20040073572A/ko not_active Withdrawn
- 2003-01-16 IL IL16276903A patent/IL162769A0/xx unknown
- 2003-01-16 RU RU2004125594/14A patent/RU2004125594A/ru not_active Application Discontinuation
- 2003-01-16 HR HR20040635A patent/HRP20040635A2/hr not_active Application Discontinuation
- 2003-01-16 EP EP20030731620 patent/EP1469861A1/en not_active Withdrawn
- 2003-01-16 MX MXPA04007071A patent/MXPA04007071A/es not_active Application Discontinuation
- 2003-01-16 WO PCT/EP2003/000373 patent/WO2003061665A1/en not_active Ceased
- 2003-01-16 CA CA002472240A patent/CA2472240A1/en not_active Abandoned
-
2004
- 2004-06-28 IS IS7338A patent/IS7338A/is unknown
- 2004-07-01 ZA ZA2004/05262A patent/ZA200405262B/en unknown
- 2004-07-06 EC EC2004005179A patent/ECSP045179A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA04007071A (es) | 2004-10-29 |
| ECSP045179A (es) | 2004-08-27 |
| US20050124592A1 (en) | 2005-06-09 |
| HRP20040635A2 (en) | 2004-10-31 |
| IS7338A (is) | 2004-06-28 |
| RU2004125594A (ru) | 2005-03-10 |
| EP1469861A1 (en) | 2004-10-27 |
| JP2005518412A (ja) | 2005-06-23 |
| CA2472240A1 (en) | 2003-07-31 |
| CN1620298A (zh) | 2005-05-25 |
| IL162769A0 (en) | 2005-11-20 |
| PL371181A1 (en) | 2005-06-13 |
| ZA200405262B (en) | 2005-08-31 |
| KR20040073572A (ko) | 2004-08-19 |
| WO2003061665A1 (en) | 2003-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Higano | Side effects of androgen deprivation therapy: monitoring and minimizing toxicity | |
| AR068702A1 (es) | Composiciones farmaceuticas | |
| MXPA05012155A (es) | Metodos y composiciones que utilizan compuestos inmunomoduladores para el tratamiento y manejo de canceres y otras enfermedades. | |
| BR9908030A (pt) | Composição farmacêutica compreendendo uma ou mais unidades de dose oralmente ministráveis, e, processos para prepará-la, para uso da mesma, e para tratar uma condição ou distúrbio médico em um indivìduo em que tratamento com um inibidor da ciclooxigenase-2 é indicado | |
| ATE457166T1 (de) | Orale zusammensetzungen zur behandlung von diabetes | |
| EP2105136A3 (en) | Pharmaceutical compositions for treating cancer | |
| BR0317747A (pt) | Método de tratamento terapêutico concomitante de um indivìduo, composição farmacêutica, kit, uso de um primeiro agente e um segundo agente, e, métodos de prevenir ou tratar uma doença relacionada com amilóide-b, doença de alzheimer e insuficiência cognitiva suave | |
| UY26130A1 (es) | Compuestos para tratar la obesidad | |
| BR0113447A (pt) | Método de tratamento ou prevenção do câncer em um ser humano, e, composição farmacêutica | |
| PH12021551023A1 (en) | Methods for shrinking pituitary tumors | |
| SG148169A1 (en) | Combination drug therapy to treat obesity | |
| BRPI0416275A (pt) | métodos de tratar, controlar ou prevenir um cáncer especìfico e uma doença associada com angiogênese indesejada | |
| MX2021003681A (es) | Composiciones y metodos para el tratamiento de desordenes inflamatorios. | |
| CY1118486T1 (el) | Λαπατινιμπη για τη θεραπεια του καρκινου | |
| BR112022010806A2 (pt) | Métodos para tratar câncer de mama, para inibir o crescimento tumoral e para prevenir ou retardar o desenvolvimento de resistência de um câncer de mama | |
| BR0015149A (pt) | Método e composições para administração de taxanos oralmente a pacientes humanos | |
| PE20031047A1 (es) | Tratamiento de padecimientos post-menopausicos en pacientes con cancer de mama | |
| FI3648788T3 (fi) | Maha-suolikanavan verenvuodon hoito vaikeaa von willebrandin tautia sairastavilla potilailla antamalla rekombinanttia vwf:ää | |
| BR0306789A (pt) | Uso de tibolona e método de tratamento de queixas relacionadas com a deficiência do estrogênio em pacientes do sexo feminino | |
| HUP0101005A2 (hu) | Szteroid aromatáz gátlót tartalmazó gyógyszer emlőrák megelőzésére és/vagy kezelésére | |
| Kasperlik-Zaluska et al. | ACTH responses to somatostatin, valproic acid and dexamethasone in Nelson's syndrome | |
| Ueha et al. | Optimization of antitumor treatment conditions for transcutaneous CO2 application: An in vivo study | |
| MX2021004885A (es) | Derivados de piperazinil y piperidinil-quinazolin-4(3h)-ona que tienen actividad contra el dolor. | |
| MX2022004121A (es) | Derivados de homopiperazinil y homopiperidinil quinazolin-4(3h)-ona que tienen actividad multimodal contra el dolor. | |
| MX2022007516A (es) | Metodos para tratar el cancer utilizando una combinacion de un antagonista de muerte programada-1, un antagonista de transcripto 4 similar a inmunoglobulina y agentes quimioterapeuticos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25A | Requested transfer of rights approved |
Owner name: N.V. ORGANON (NL) Free format text: TRANSFERIDO DE: AKZO NOBEL N.V. |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6O E 7O ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2047 DE 30/03/2010. |